
Intellectual Property
Viewpoints
Filter by:
Arbitration of SEP Disputes—A Growing Trend?
April 11, 2025 | Blog | By Matthew Hurley, Matthew Galica, Amanda Metell
Understanding How to Patent Agentic AI Systems
March 20, 2025 | Blog | By Frank Gerratana, Neil Supnekar
Trade Secret Owners Need to Find the Facts Instead of Letting the Facts Find Them
March 14, 2025 | Blog | By Reza Dokhanchy, Laura Petrasky, Michael Renaud
Patenting AI/ML Life Sciences and TechBio Innovations – How Much Disclosure is Sufficient?
February 24, 2025 | Blog | By Hanna Kim, PhD, Terri Shieh-Newton
UPC Risks Unveiled: Navigating Outcome Trends and Parallel Revocation Strategies
February 12, 2025 | Blog | By Michael Van Loy, Carolina Säve
Year in Review: The Most Popular IP Posts of 2024
January 6, 2025 | Blog | By Christina Sperry
What To Do Now That The AFCP (After Final Consideration Program) Is Ending?
December 2, 2024 | Blog | By Christina Sperry
Contemplating the Impact of the USPTO’s AI-Focused Patent Eligibility Guidance on Networking Applications
October 9, 2024 | Blog | By Frank Gerratana, Jonathon Western
New guidance issued by the United States Patent and Trademark Office (USPTO) on patent subject matter eligibility under 35 U.S.C. § 101, focusing on AI and other software-related emerging technologies.
Federal Circuit Rejects Google’s Bid To Shrink ITC Jurisdiction over Post-Importation Acts of Indirect Infringement
September 12, 2024 | Blog | By David H. Hollander, Matthew Karambelas, Michael Renaud, Adam Rizk
In the wake of the Supreme Court’s elimination of “Chevron deference” in the Loper decision, many commentators have suggested that the ITC’s authority over unfair imports under Section 337 might be curtailed.
Understanding the 2024 USPTO Guidance Update on AI Patent Eligibility
July 25, 2024 | Blog | By Frank Gerratana, Terri Shieh-Newton, Qi Zhang
The United States Patent and Trademark Office (USPTO) has issued an important update to its guidance on patent subject matter eligibility.
Supreme Court Doesn’t Want to Play the Name Game: Prohibition Against Using a Person’s Name in a Registered Mark Without Consent Remains Constitutional
July 22, 2024 | Blog | By Laura Franco
This case is a victory for public figures and their control over their personal branding. Applicants for trademark registration must continue to get clearance before incurring the significant cost of registration when using a living person’s name. While this decision is likely to have minimal impact on most trademark filings, it does come as part of a larger trend of the Court’s willingness to address longstanding provisions of the Lanham Act. And should Justice Barrett’s prophesy come to pass, this may not be the last word on content-based, view-point neutral restrictions.
Assessing the Impact of Recent Supreme Court Decisions on ITC Practice – Less than Meets the Eye?
July 17, 2024 | Blog | By David H. Hollander, Matthew Karambelas, Michael Renaud, Adam Rizk
Late last month, the Supreme Court issued two opinions which seemingly shook up the field of administrative law. As explained in this article, however, while both decisions bear significantly on certain administrative agencies, neither of these decisions are likely to present significant changes to Section 337 practice at the International Trade Commission.
Explore Other Viewpoints:
- Data Centers & Digital Infrastructure
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- DEI Legal Developments
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- EnforceMintz
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Sustainable Energy & Infrastructure
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Unified Patent Court (UPC)
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology